| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:47:05 UTC |
|---|
| Update Date | 2022-11-30 19:25:55 UTC |
|---|
| HMDB ID | HMDB0114811 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(14:1(9Z)/24:1(15Z)) |
|---|
| Description | PA(14:1(9Z)/24:1(15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:1(9Z)/24:1(15Z)), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCC\C=C/CCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC InChI=1S/C41H77O8P/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-14-12-10-8-6-4-2/h10,12,16-17,39H,3-9,11,13-15,18-38H2,1-2H3,(H2,44,45,46)/b12-10-,17-16-/t39-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Myristoleoyl-2-nervonoyl-sn-glycero-3-phosphate | HMDB | | 1-Myristoleoyl-2-nervonoyl-sn-phosphatidic acid | HMDB | | PA(14:1/24:1) | HMDB | | PA(14:1N5/24:1N9) | HMDB | | PA(14:1W5/24:1W9) | HMDB | | PA(38:2) | HMDB | | Phosphatidic acid(14:1(9Z)/24:1(15Z)) | HMDB | | Phosphatidic acid(14:1/24:1) | HMDB | | Phosphatidic acid(14:1n5/24:1n9) | HMDB | | Phosphatidic acid(14:1W5/24:1W9) | HMDB | | Phosphatidic acid(38:2) | HMDB | | Phosphatidate(14:1(9Z)/24:1(15Z)) | HMDB | | Phosphatidate(14:1/24:1) | HMDB | | Phosphatidate(14:1N5/24:1N9) | HMDB | | Phosphatidate(14:1W5/24:1W9) | HMDB | | Phosphatidate(38:2) | HMDB | | [(2R)-2-[(15Z)-Tetracos-15-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonate | HMDB | | 1-myristoleoyl-2-nervonoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-myristoleoyl-2-nervonoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(14:1/24:1) | SMPDB, HMDB | | PA(14:1n5/24:1n9) | SMPDB, HMDB | | PA(14:1w5/24:1w9) | SMPDB, HMDB | | PA(38:2) | SMPDB, HMDB | | Phosphatidic acid(14:1(9Z)/24:1(15Z)) | SMPDB, HMDB | | Phosphatidic acid(14:1/24:1) | SMPDB, HMDB | | Phosphatidic acid(14:1n5/24:1n9) | SMPDB, HMDB | | Phosphatidic acid(14:1w5/24:1w9) | SMPDB, HMDB | | Phosphatidic acid(38:2) | SMPDB, HMDB | | Phosphatidate(14:1(9Z)/24:1(15Z)) | SMPDB, HMDB | | Phosphatidate(14:1/24:1) | SMPDB, HMDB | | Phosphatidate(14:1n5/24:1n9) | SMPDB, HMDB | | Phosphatidate(14:1w5/24:1w9) | SMPDB, HMDB | | PA(14:1(9Z)/24:1(15Z)) | SMPDB |
|
|---|
| Chemical Formula | C41H77O8P |
|---|
| Average Molecular Weight | 729.033 |
|---|
| Monoisotopic Molecular Weight | 728.535606437 |
|---|
| IUPAC Name | [(2R)-2-[(15Z)-tetracos-15-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(15Z)-tetracos-15-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCC\C=C/CCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C41H77O8P/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-26-28-30-32-34-36-41(43)49-39(38-48-50(44,45)46)37-47-40(42)35-33-31-29-27-25-14-12-10-8-6-4-2/h10,12,16-17,39H,3-9,11,13-15,18-38H2,1-2H3,(H2,44,45,46)/b12-10-,17-16-/t39-/m1/s1 |
|---|
| InChI Key | GDDLDQULBNDGMO-ZDMXYWDMSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/24:1(15Z)) (PathBank: SMP0088755)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/14:1(9Z)) (PathBank: SMP0020919)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/16:1(9Z)) (PathBank: SMP0020920)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/18:1(11Z)) (PathBank: SMP0020921)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/18:1(9Z)) (PathBank: SMP0020922)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:1(11Z)) (PathBank: SMP0020923)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0020924)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/22:1(13Z)) (PathBank: SMP0020925)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/18:2(9Z,12Z)) (PathBank: SMP0020927)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0020928)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0020929)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/22:2(13Z,16Z)) (PathBank: SMP0020930)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0020931)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0020932)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0020933)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0020934)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0020935)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0020936)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0020937)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0020938)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:2(11Z,14Z)) (PathBank: SMP0032619)
- De Novo Triacylglycerol Biosynthesis TG(14:1(9Z)/24:1(15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0032620)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.85 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 36.4116 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.01 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5295.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 584.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 373.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 261.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1104.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1842.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1375.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 258.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3711.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1150.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2899.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1392.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 745.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 646.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 870.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(14:1(9Z)/24:1(15Z)),1TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 5151.1 | Semi standard non polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),1TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 4522.0 | Standard non polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),1TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 5838.3 | Standard polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),2TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 5072.8 | Semi standard non polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),2TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 4497.9 | Standard non polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),2TMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 5059.9 | Standard polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),1TBDMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 5387.0 | Semi standard non polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),1TBDMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 4612.9 | Standard non polar | 33892256 | | PA(14:1(9Z)/24:1(15Z)),1TBDMS,isomer #1 | CCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O[Si](C)(C)C(C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | 5822.9 | Standard polar | 33892256 |
|
|---|